Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE

Abstract Background Sodium zirconium cyclosilicate (SZC) is an effective and well-tolerated treatment for hyperkalemia in maintenance hemodialysis patients. In post-hoc analyses of the phase 3b DIALIZE study, we examined the spectrum of potassium responses to SZC. Methods Post-hoc analyses with SZC...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Steven Fishbane, Martin Ford, Masafumi Fukagawa, Kieran McCafferty, Anjay Rastogi, Bruce Spinowitz, Konstantin Staroselskiy, Konstantin Vishnevskiy, Vera Lisovskaja, Ayman Al-Shurbaji, Nicolas Guzman, Sunil Bhandari
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2022-02-01
coleção:	BMC Nephrology
Assuntos:	Hemodialysis Chronic kidney disease Potassium Hyperkalemia Sodium zirconium cyclosilicate
Acesso em linha:	https://doi.org/10.1186/s12882-021-02569-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!